Home » Icagen Receives Milestone Payment From Yamanouchi Pharmaceutical Co., Ltd.
Icagen Receives Milestone Payment From Yamanouchi Pharmaceutical Co., Ltd.
March 15, 2005
Icagen, Inc. announced that it has received a milestone payment from Yamanouchi Pharmaceutical Co., Ltd. related to the selection of a compound for advanced preclinical studies as a result of the collaboration between the two companies in dementia, including Alzheimer's disease.
Yahoo News (http://biz.yahoo.com/prnews/050315/nytu071_2.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct